Protective effect of montelukast which is cysteinyl-leukotriene receptor antagonist on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney

Renal Failure

Volumn 35, Issue 3, 2013, Pages 403-410

  Otunctemur, Alper ^a   Ozbek, Emin ^a   Cekmen, Mustafa ^b   Cakir, Suleyman Sami ^a   Dursun, Murat ^a   Polat, Emre Can ^c   Somay, Adnan ^d   Ozbay, Nurver ^d  

^a Department of Urology Okmeydani Training and Research Hospital ^*  (Turkey)

^b KOCAELI UNIVERSITY   (Turkey)

^c PMR Department   (Turkey)

^d FATIH SULTAN MEHMET TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Gentamicin; Montelukast; Nephrotoxicity; Nitric oxide; Reactive oxygen species

Indexed keywords

CREATININE; GENTAMICIN; GLUTATHIONE; MALONALDEHYDE; MONTELUKAST; NITRIC OXIDE; UREA; ACETIC ACID DERIVATIVE; ANTIINFECTIVE AGENT; LEUKOTRIENE D4 RECEPTOR; LEUKOTRIENE RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; QUINOLINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FIBROSING ALVEOLITIS; GLOMERULUS; HISTOPATHOLOGY; KIDNEY CORTEX; KIDNEY PARENCHYMA; KIDNEY TUBULE NECROSIS; MORPHOLOGY; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL PROTECTION; UREA BLOOD LEVEL; URINALYSIS; URINE VOLUME; ACUTE KIDNEY INJURY; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; DRUG SCREENING; KIDNEY; MALE; METABOLISM; PATHOLOGY; URINE; WISTAR RAT;

ACETATES; ACUTE KIDNEY INJURY; ANIMALS; ANTI-BACTERIAL AGENTS; DRUG EVALUATION, PRECLINICAL; GENTAMICINS; KIDNEY; LEUKOTRIENE ANTAGONISTS; MALE; QUINOLINES; RATS; RATS, WISTAR; RECEPTORS, LEUKOTRIENE; URINE;

EID: 84875010518     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.761040     Document Type: Article

References (61)

1. Mahmood I, Waters DH. A comparative study of uranyl nitrate and cisplatin induced renal failure in rat. Eur J Drug Metab Pharmacol. 1994;19:327-336
2. Begg EJ, Barclay ML. Aminoglycisides-50 years on. Br J Clin Pharmacol. 1995;39:597-603
3. Fatima S, Yusufi ANK, Mahmood R. Effect of cisplatin on renal brush border membrane enzymes and phosphate transport. Hum Exp Toxicol. 2004;23:547-554
4. Humes HD, Weinberg JM. Toxic nephropathies. In: Brenner BM, Rector FC, eds. The Kidney. Philadelphia, PA: W.B. Saunders Co.; 1986:1491-1532
5. Mingeot-Leclercq MP, Tulkens PM. Aminoglycosides: Nephrotoxicity. Antimicrob Agents Chemother. 1999;43:1003-1012
6. Nagai J, Takano M. Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity. Drug Metab Pharmacokinet. 2004;19:159-170
7. Karadeniz A, Yildirim A, Simsek N, Kalkan Y, Celebi F. Spirulina platensis protects against gentamicin-induced nephrotoxicity in rats. Phytother Res. 2008;22:1506-1510
8. Leehey DJ, Braun BI, Tholl DA, et al. Can pharmacokinetic dosing decrease nephrotoxicity associated with aminoglycoside therapy. J Am Soc Nephrol. 1993;4:81-90
9. Schmitz C, Hilpert J, Jacobsen C, et al. Megalin deficiency offers protection from renal aminoglycoside accumulation. J Biol Chem. 2002;277:618-622
10. Servais H, Van Der Smissen P, Thirion G, et al. Gentamicininduced apoptosis in LLC-PK1 cells: Involvement of lysosomes and mitochondria. Toxicol Appl Pharmacol. 2005;206:321-333
11. Servais H, Jossin Y, Van Bambeke F, Tulkens PM, Mingeot-Leclercq MP. Gentamicin causes apoptosis at low concentrations in renal LLC-PK1 cells subjected to electroporation. Antimicrob Agents Chemother. 2006;50:1213-1221
12. Sandoval RM, Molitoris BA. Gentamicin traffics retrograde through the secretory pathway and is released in the cytosol via the endoplasmic reticulum. Am J Physiol Renal Physiol. 2004;286: F617-F624
13. Geleilete TJ, Melo GC, Costa RS, Volpini RA, Soares TJ, Coimbra TM. Role of myofibroblasts, macrophages, transforming growth factor-beta endothelin, angiotensin-II, and fibronectin in the progression of tubulointerstitial nephritis induced by gentamicin. J Nephrol. 2002;15:633-642
14. El Mouedden M, Laurent G, Mingeot-Leclercq MP, Tulkens PM. Gentamicin-induced apoptosis in renal cell lines and embryonic rat fibroblasts. Toxicol Sci. 2000;56:229-239
15. Walker PD, Barri Y, Shah SV. Oxidant mechanisms in gentamicin nephrotoxicity. Ren Fail. 1999;21:433-442
16. Cuzzocrea S, Mazzon E, Dugo L, et al. A role for superoxide in gentamicin-mediated nephropathy in rats. Eur. J Pharmacol. 2002;450:67-76
17. Diamond JR, Kees-Folts D, Ding G, Frye JE, Restrepo NC. Macrophages, monocyte chemoattractant peptide-1, and TGFbeta 1 in experimental hydronephrosis. Am J Physiol. 1994;266: F926-F933
18. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol. 1998;10:248-253
19. Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Arnal JF, Michel JB. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol. 2000;20:645-651
20. Tang WW, Feng L, Mathison JC, Wilson CB. Cytokine expression, upregulation of intercellular adhesion molecule-1, and leukocyte infiltration in experimental tubulointerstitial nephritis. Lab Invest. 1994;70:631-638
21. Ali BH. Agents ameliorating or augmenting experimental gentamicin nephrotoxicity: Some recent research. Food Chem Toxicol. 2003;41:1447-1452
22. Nagai J, Takano M. Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity. Drug Metab Pharmacokin. 2004;19:159-170
23. Kelly KJ, Williams WW, Colvin RB, et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest. 1996;97:1056-1063
24. Damtew B, Marino JA, Fratianne RB, Spagnuolo PJ. Neutrophil lipoxygenase metabolism and adhesive function following acute thermal injury. J Lab Clin Med. 1993;121:328-336
25. Wallace JL, Beck PL, Morris GP. Is there a role for leukotrienes as mediators of ethanol-induced gastric mucosal damage? Am J Physiol. 1988;254: G117-G123
26. Carsin H, Bargues L, Stephanazzi J, Paris A, Aubert P, Le Bever H. Inflammatory reaction and infection in severe burns. Pathol Biol. 2002;50:93-101
27. Wallace JL, McKnight GW, Keenan CM, Byles NI, MacNaughton WK. Effects of leukotrienes on susceptibility of the rat stomach to damage and investigation of the mechanismof action. Gastroenterology. 1990;98:1178-1186
28. Konturek SJ, Brozozowski T, Drozdowicz D, Beck G. Role of leukotrienes in acute gastric lesions induced by ethanol, taurocholate, aspirin, platelet-Activating factor and stress in rats. Dig Dis Sci. 1988;33:806-813
29. Sener G, Kabasakal L, Cetinel S, Contuk G, Gedik N, Yegen B. Leukotriene receptor blocker montelukast protects against burninduced oxidative injury of the skin and remote organs. Burns. 2005;31:587-596
30. Sener G, Sehirli O,Cetinel S, et al. Amelioration of sepsisinduced hepatic and ileal injury in rats by the leukotriene receptor blocker montelukast. Prostoglandins Leukot Essent Fatty Acids. 2005;73:453-462
31. Villegas I,Martín AR, TomaW, et al. Rosiglitazone, an agonist of peroxisome proliferator-Activated receptor c, protects against gastricischemia-reperfusion damage in rats: Role of oxygen free radicals generation. Eur J Pharmacol. 2004;505:195-203
32. Wasowicz W, Neve J, Peretz A. Optimized steps in fluorometric determination thiobarbituric acid-reactive substances in serum: Importance of extraction pH and influence sample preservation and storage. Clin Chem. 1993;39:2522-2528
33. Beutler E. Glutathione in Red Blood Cell Metabolism. A Manual of Biochemical Methods. New York: Grune and Stratton; 1975: 112-114
34. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1998;34:497-500
35. Allen CT. Laboratory methods in histochemistry. In: Prophet EB, Mills B, Arrington JB, Sobin LH, eds. American Registry of Pathology. 1st ed. Washington DC: Armed Forces Institute of Pathology; 1992:53
36. Ayyildiz A, Nuhoǧlu B, Gülerkaya B, Caydere M, Ustün H, Germiyanoglu C, et al. Effect of intraurethral mitomycin C on healing and fibrosis in rats with experimentally induced urethral stricture. Int J Urol. 2004;11:1122-1126
37. Humes HD, Connor RPO. Aminoglycoside nephrotoxicity. In: Schrier RW, Gottschalk CW, eds. Diseases of the Kidney. Vol. 2. no. 4. Boston, MA: Little Brown; 1988:1229-1273
38. Abdel-Gayoum AA, Ali BH, Abdel-Razig AA, Bashir AA, Ghywarsha K. Effect of gentamicin-induced nephrotoxicity on some carbohydrate metabolic pathways in the rat renal cortex. Arch Toxicol. 1994;68:643-647
39. Ali BH, Bashir AA. Effect of fish oil treatment on gentamicin nephrotoxicity in rats. Anal Nutr Metab. 1994;38:336-339
40. Humes HD. Aminoglycoside nephrotoxicity. Kidney Int. 1988;33:900-911
41. Simmons CF Jr, Bogusky RT, Humes HD. Inhibitory effects of gentamicin on renal mitochondrial oxidative phosphorylation. J Pharmacol Exp Ther. 1980;214:709-715
42. Aharony D. Pharmacology of leukotriene receptor antagonists. Am J Respir Crit Care Med. 1998;157:S214-S219
43. O'Byrne PM. Asthma treatment: Antileukotriene drugs. Can Respir J. 1998;5(Suppl. A):64A-70A
44. Wenzel SE. Leukotriene receptor antagonists and related compounds. Can Respir J. 1999;6:189-193
45. Wallace JL, MacNaughton WK, Morris GP, Beck PL. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology. 1989;96:29-36
46. Wallace JL, McKnight GW, Keenan CM, Byles NI, MacNaughton WK. Effects of leukotrienes on susceptibility of the rat stomach to damage and investigation of the mechanism of action. Gastroenterology. 1990;98:1178-1186
47. Silan C, Uzun O, Comunoglu NU, Gokcen S, Bedirhan S, Cengiz M. Gentamicin-induced nephrotoxicity in rats ameliorated and healing effects of resveratrol. Biol Pharm Bull. 2007;30:79-83
48. Cronin RE, Thompson Jr. Role of potassium in the pathogenesis of acute renal failure. Miner Electrolyte Metab. 1991;17: 100-105
49. Mohamed Said M. The protective effect of eugenol against gentamicin-induced nephrotoxicity and oxidative damage in rat kidney. Fund Clin Pharmacol. 2011;25:708-716
50. Burkhardt S, Reiter RJ, Tan D-X, Hardeland R, Cabrera J, Karbownik M. DNA oxidatively damaged by chromium(III) and H2O2 is protected by the antioxidant melatonin, N1-Acetyl-N2-formyl-5-methoxykynuramine, resveratrol and uric acid. Int J Biochem Cell Biol. 2001;33:775-783
51. Oberg BP, Mc Menamin E, Lucas FL, et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic renal disease. Kidney Int. 2004;65: 1009-1016
52. Ece A, Atamer Y, Gurkan F, et al. Paraoxonae, anti-oxidant response and oxidative stress in children with chronic renal failure. Pediatr Nephrol. 2006;21:239-245
53. Reiter RJ, Acuno-Castroviejo D, Tan DX, Burkhardt S. Free radical-mediated molecular damage, Ann. NY Acad Sci. 2001;939:200-215
54. Ross D. Glutathione, free radicals and chemotherapeutic agents. Pharmac Ther. 1988;37:231-249
55. Paller MS, Patten M. Protective effects of glutathione, glycine, or alanine in an in vitro model of renal anoxia. J Am Soc Nephrol. 1992;2:1338-1344
56. Mandel LJ, Schnellmann RG, William RJ. Intracellular glutathione in the protection from anoxic injury in renal proximal tubules. J Clin Invest. 1989;85:316-324
57. Houghton DC, English J, Bennett WM. Chronic tubulointerstitial nephritis and renal insufficiency associated with longterm "subtherapeutic" gentamicin. J Lab Clin Med. 1988;112: 694-703
58. Fuhr J, Kaczmarczyk J, Kruttgen CD. A simple colorimetric method of inulin determination in renal clearance studies on metabolically normal subjects and diabetics. Klin Wochenschr. 1955;33:729-730
59. Kumar KV, Shifow AA, Naidu MU, et al. Carvedilol: A beta blocker with antioxidant property protects against gentamicininduced nephrotoxicity in rats. Life Sci. 2000;66:2603-2611
60. Nakakuki M, Yamasaki F, Shinkawa T, et al. Protective effect of human ulinastatin against gentamicin-induced acute renal failure in rats. Can J Phys Pharmacol. 1996;74:104-111
61. Ozbek E, Cekmen M, Ilbey YO, et al. Atorvastatin prevents gentamicin-induced renal damage in rats through the inhibition of p38-MAPK and NF-kB pathways. Renal Fail. 2009;31: 382-392